Pay in 4 interest-free payments of $9.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Molecular Weight: 520
Dibirdik I
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
PubMed PMID: 23665028
Decreased activity and expression of the cardiac sarcoplasmic reticulum calcium ATPase (SERCA2a)
GSK-J1 - H3K27 Histone Demethylases UTX and JMJD3 Inhibitor. CAS# 1373422-53-7 size:2mg solid Molecular Weight: 520GSK J1, CAS No. 1373422 53 7, is the first selective and potent inhibitor of the H3K27 histone demethylases UTX and JMJD3. H3K27 methylations play important roles in regulating gene expression through the polycomb repressive complex (PRC1 or PRC2). This epigenetic mark can be demethylated by lysine demethylase (KDM) UTX and JMJD3, which play important roles in cellular differentiation, development and cancer. In relevant biological assays, GSK J1 was
US$ 35.95
US$ 10.00
US$ 16.00